Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.36 USD | +2.13% | +3.38% | +97.65% |
Apr. 25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 24.5M |
---|---|---|---|---|---|
Net income 2022 | -9M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 42.06M | Net cash position 2023 | 37.15M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.44
x | P/E ratio 2023 |
-4.59
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.71% |
1 day | +2.13% | ||
1 week | +3.38% | ||
Current month | -3.72% | ||
1 month | +12.00% | ||
3 months | +103.64% | ||
6 months | +82.61% | ||
Current year | +97.65% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 06-09-30 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 21-05-09 |
Sharon Perry
LAW | General Counsel | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 17-02-15 |
Robert Conway
CHM | Chairman | 70 | 13-09-02 |
Linda Grais
BRD | Director/Board Member | 68 | 07-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 3.36 | +2.13% | 41,052 |
24-05-07 | 3.29 | +2.17% | 33,624 |
24-05-06 | 3.22 | -1.23% | 51,815 |
24-05-03 | 3.26 | 0.00% | 16,949 |
24-05-02 | 3.26 | +0.31% | 66,037 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+97.65% | 48.74M | |
+2.93% | 108B | |
-3.70% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- ABIO Stock